News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Patheon Inc. (PTI.TO) Restructure Complete; New Company, DPx Expects $2 Billion In Annual Sales


3/11/2014 12:02:06 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Restructuring of the former Patheon Pharmaceuticals has been completed, and the pharmaceutical services company is now a business unit of DPx Holdings B.V. (DPx).

DPx is privately owned by JLL Partners and Royal DSM and launched as a global contract development and manufacturing organization (CDMO) for the pharmaceutical and related industries. DPx is the result of a $2.65 billion transaction between JLL Partners, a middle-market private equity firm, and Royal DSM, a Netherlands-based life sciences conglomerate.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES